<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00505830</url>
  </required_header>
  <id_info>
    <org_study_id>Autisme AQ</org_study_id>
    <nct_id>NCT00505830</nct_id>
  </id_info>
  <brief_title>Evaluation of the French Version of Screening Questionnaires for Autism and Asperger Syndrome: AQ, EQ and SQ</brief_title>
  <official_title>Evaluation of the French Version of Screening Questionnaires for Autism and Asperger Syndrome : Autism Spectrum Quotient (AQ) Empathy Quotient (EQ) and Systemizing Quotient (SQ)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Groupe Francais d'Epidemiologie Psychiatrique</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Joint Clinical Research Center</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Groupe Francais d'Epidemiologie Psychiatrique</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Autism is considered as an invading disorder of the development. Asperger Syndrome (AS) is a&#xD;
      particular form of autism and is difficult to diagnose. The Autism Spectrum Quotient (AQ) has&#xD;
      been developed in order to measure the degree of autistic traits in autistic adolescent with&#xD;
      normal intelligence (Baron-Cohen et al. 2001, 2006). AQ comprises 50 questions, with 5 groups&#xD;
      of 10 questions assessing imagination, social skills, attention switching, attention to&#xD;
      detail and communication skills. Each of these items scores 1 point if the respondent records&#xD;
      abnormal or autistic like behaviour. The minimum score on the AQ is 0 and the maximum 50.&#xD;
&#xD;
      The principal objective of this study is to evaluate the accuracy of the French version of&#xD;
      Autism Spectrum Quotient questionnaire.&#xD;
&#xD;
      Secondary objectives are to:&#xD;
&#xD;
      Evaluate if EQ and SQ can distinguish adolescents without psychiatric syndromes from those&#xD;
      with classical autism or AS.&#xD;
&#xD;
      Evaluate if AQ, EQ and SQ can distinguish adolescents with psychiatric disorders from&#xD;
      autistic adolescents.&#xD;
&#xD;
      Define the threshold of positivity for the 3 questionnaires.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      4 groups of participants will be screened with the questionnaires: Group 1: 50 adolescents&#xD;
      with AS or high functioning autism (HFS) diagnosed by psychiatrists using established&#xD;
      criteria and with an IQ &gt;85.&#xD;
&#xD;
      Group 2: 50 adolescents with AS or classical autism diagnosed by psychiatrists using&#xD;
      established criteria 70&lt;IQ&lt;84.&#xD;
&#xD;
      Group 3: 50 adolescents with psychiatric disorders. Group 4: Sample of 50 healthy adolescents&#xD;
      selected randomly from 200. The questionnaires are given to the parents of adolescents during&#xD;
      the first meeting. Parents are invited to send them back to the clinical investigation centre&#xD;
      of Lyon (France).&#xD;
&#xD;
      Multicentre study: 8 clinical centres and 18 paediatricians&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>July 2007</start_date>
  <completion_date type="Anticipated">July 2009</completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Defined Population</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <number_of_groups>4</number_of_groups>
  <enrollment type="Anticipated">450</enrollment>
  <condition>Asperger Syndrome</condition>
  <condition>Autism</condition>
  <arm_group>
    <arm_group_label>1</arm_group_label>
    <description>50 adolescents with AS or high functioning autism (HFS) diagnosed by psychiatrists using established criteria and with an IQ &gt;85.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2</arm_group_label>
    <description>50 adolescents with AS or classical autism diagnosed by psychiatrists using established criteria 70&lt;IQ&lt;84.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>3</arm_group_label>
    <description>50 adolescents with psychiatric disorders but no autism syndrom.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>4</arm_group_label>
    <description>Sample of 50 healthy adolescents selected randomly from 200.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>questionnaires</intervention_name>
    <description>Primary outcome:&#xD;
Autism Spectrum Quotient (AQ)&#xD;
Secondary outcome measure:&#xD;
Empathy quotient (EQ) Systemizing quotient (SQ) WISC III or WISC IV ADOS score ADI score</description>
    <arm_group_label>1</arm_group_label>
    <arm_group_label>2</arm_group_label>
    <arm_group_label>3</arm_group_label>
    <arm_group_label>4</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        Group 1 (AS/HFA) and 2 (AS/classic autism) :&#xD;
&#xD;
          -  Boys and girls aged 12 to 18&#xD;
&#xD;
          -  Patients with autism or Asperger syndrome according to the diagnostic criteria (ICD&#xD;
             10)&#xD;
&#xD;
          -  Patients receiving education in an ordinary school&#xD;
&#xD;
          -  IQ&gt;70&#xD;
&#xD;
        Group 3 (adolescents with psychiatric disorders):&#xD;
&#xD;
          -  Boys and girls aged 12 to 18&#xD;
&#xD;
          -  Patients hospitalized on a psychiatric ward or at a psychiatrics patient visit or&#xD;
             psychiatric consultation wit hout autistic syndrome&#xD;
&#xD;
          -  Patients receiving education in an ordinary school when not in hospital&#xD;
&#xD;
        Group 4 (adolescent without psychiatric syndrome):&#xD;
&#xD;
          -  Boys and girls aged 12 to 18&#xD;
&#xD;
          -  Patients receiving education in an ordinary school&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
        For all groups :&#xD;
&#xD;
          -  Problem with language or comprehension&#xD;
&#xD;
          -  Participants who have not given their consent&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>12 Years</minimum_age>
    <maximum_age>18 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Sabine Manificat, MDH</last_name>
    <role>Principal Investigator</role>
    <affiliation>Centre Hospitalier Saint Jean de Dieu</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Jean-Pierre Vignat, MDH</last_name>
    <phone>+33 4 37 90 11 75</phone>
    <email>jpvignat@ch-st-jean-de-dieu-lyon.fr</email>
  </overall_contact>
  <location>
    <facility>
      <name>Centre Hospitalier Saint Jean de Dieu</name>
      <address>
        <city>Lyon</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Sabine Manificat, MDH</last_name>
      <phone>+33 4 37 90 12 96</phone>
      <email>smanificat@arhm-sjd.fr</email>
    </contact>
    <contact_backup>
      <last_name>Berhouz Kassai, MD, PhD</last_name>
      <email>bk@upcl.univ-lyon1.fr</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>July 2007</verification_date>
  <study_first_submitted>July 23, 2007</study_first_submitted>
  <study_first_submitted_qc>July 23, 2007</study_first_submitted_qc>
  <study_first_posted type="Estimate">July 25, 2007</study_first_posted>
  <last_update_submitted>July 23, 2007</last_update_submitted>
  <last_update_submitted_qc>July 23, 2007</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 25, 2007</last_update_posted>
  <keyword>Asperger Syndrom</keyword>
  <keyword>Autism Quotient</keyword>
  <keyword>French version</keyword>
  <keyword>screening</keyword>
  <keyword>diagnostic test</keyword>
  <keyword>accuracy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Syndrome</mesh_term>
    <mesh_term>Autistic Disorder</mesh_term>
    <mesh_term>Asperger Syndrome</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

